Mancosu, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 6.623
AS - Asia 3.796
EU - Europa 1.308
SA - Sud America 758
AF - Africa 189
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.698
Nazione #
US - Stati Uniti d'America 6.514
SG - Singapore 2.334
BR - Brasile 621
CN - Cina 562
VN - Vietnam 467
DE - Germania 347
FI - Finlandia 216
IE - Irlanda 196
NG - Nigeria 116
FR - Francia 115
HK - Hong Kong 109
IT - Italia 91
NL - Olanda 75
GB - Regno Unito 72
IN - India 59
CA - Canada 51
AR - Argentina 45
RU - Federazione Russa 39
SE - Svezia 38
TR - Turchia 36
BD - Bangladesh 32
IQ - Iraq 32
EC - Ecuador 30
MX - Messico 27
CL - Cile 21
ID - Indonesia 20
IL - Israele 19
PK - Pakistan 19
AT - Austria 18
PL - Polonia 17
SA - Arabia Saudita 17
ZA - Sudafrica 17
AU - Australia 15
BE - Belgio 15
ES - Italia 15
MA - Marocco 13
VE - Venezuela 12
UA - Ucraina 11
UZ - Uzbekistan 11
CO - Colombia 10
CZ - Repubblica Ceca 10
KZ - Kazakistan 10
DZ - Algeria 9
EG - Egitto 9
JP - Giappone 9
MY - Malesia 9
OM - Oman 9
JO - Giordania 8
HN - Honduras 7
PY - Paraguay 7
KE - Kenya 6
NP - Nepal 6
PE - Perù 6
TN - Tunisia 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
LT - Lituania 5
PH - Filippine 5
RO - Romania 5
UY - Uruguay 5
AZ - Azerbaigian 4
CR - Costa Rica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
DK - Danimarca 3
PS - Palestinian Territory 3
UG - Uganda 3
CH - Svizzera 2
EU - Europa 2
GD - Grenada 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
KR - Corea 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
Totale 12.686
Città #
Dallas 1.094
Singapore 1.070
Wilmington 942
Chandler 742
San Mateo 361
The Dalles 328
Ashburn 264
Ann Arbor 253
Shanghai 251
Falkenstein 226
Helsinki 215
Dublin 193
Leawood 173
San Jose 165
Lawrence 154
Princeton 154
Boardman 141
Ho Chi Minh City 135
Hanoi 124
Beijing 116
Benin City 116
Fairfield 114
Hong Kong 90
New York 90
Woodbridge 87
Paris 79
Amsterdam 64
São Paulo 58
Seattle 36
Santa Clara 35
London 31
Los Angeles 30
Milan 26
San Diego 26
Toronto 23
Rio de Janeiro 22
Da Nang 21
Norwalk 21
Haiphong 20
Council Bluffs 18
Belo Horizonte 17
Orem 17
Brussels 15
Kocaeli 15
Baghdad 14
Chennai 12
Columbus 12
Curitiba 12
Guayaquil 12
Hillsboro 12
Vienna 12
Biên Hòa 11
Frankfurt am Main 11
Johannesburg 11
Boos 10
Campinas 10
Can Tho 10
Mexico City 10
Montreal 10
Tashkent 10
Brasília 9
Munich 9
Ninh Bình 9
Nuremberg 9
Phoenix 9
Porto Alegre 9
Quito 9
Salvador 9
Des Moines 8
Dhaka 8
Fortaleza 8
Guarulhos 8
Redwood City 8
Santiago 8
Thái Bình 8
Tokyo 8
Warsaw 8
Amman 7
Brooklyn 7
Hải Dương 7
Lahore 7
Moscow 7
Redmond 7
Asunción 6
Bathurst 6
Buffalo 6
Genoa 6
Goiânia 6
Monmouth Junction 6
Riyadh 6
San Francisco 6
Santo André 6
Ankara 5
Astana 5
Berlin 5
Cairo 5
Denver 5
Erbil 5
Houston 5
Jeddah 5
Totale 8.631
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 745
11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity 675
"Early Clinical Assessment Of Feasibility And Safety In Flattering Filter Free (FFF) Based Stereotactic Body Radiotherapy (SBRT) Treatments" 133
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 115
SALVAGE RADIOTHERAPY WITH VOLUMETRIC MODULATION ARC THERAPY AND HYPOFRACTIONATION FOR RECURRENT PROSTATE CANCER AFTER HIFU FAILURE 103
Accuracy evaluation of the optical surface monitoring system on EDGE linear accelerator in a phantom study. 100
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 98
Cranio-spinal irradiation with volumetric modulated arc therapy: A multi-institutional treatment experience 96
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 95
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 94
Applying failure mode effects and criticality analysis in radiotherapy: Lessons learned and perspectives of enhancement 90
Early Surgical Experience with Minimally Invasive Percutaneous Approach for Patients with Metastatic Epidural Spinal Cord Compression (MESCC) to Poor Prognoses 87
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases 87
Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients 82
CRITICAL APPRAISAL OF VOLUMETRIC MODULATED ARC THERAPY IN STEREOTACTIC BODY RADIATION THERAPY FOR METASTASES TO ABDOMINAL LYMPH NODES 82
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 82
Organs at risk in lung SBRT 81
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 81
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments. 81
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 81
Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer 80
Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT. 79
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer 79
Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case 78
Comparison of low dose total marrow/total lymphoid irradiation (TMI/TLI) and TBI in haploidentical transplant platform: a retrospective analysis 77
Dosimetric evaluation of different radiotherapy modalities and calculations for soft tissue sarcoma 77
VOLUMETRIC MODULATION ARC RADIOTHERAPY COMPARED WITH STATIC GANTRY INTENSITY-MODULATED RADIOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA TUMOR: A FEASIBILITY STUDY 77
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 76
Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer Report of feasibility and acute toxicity 75
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery. 75
Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: Feasibility and clinical preliminary results 75
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 75
SBRT Dose Escalation Phase II Study for Liver Metastases Using Volumetric Modulated Arc Therapy (VMAT-RapidArc) 75
Stereotactic Body Radiation Therapy (SBRT) for adrenal metastases A Feasibility Study of Advanced Techniques with Modulated Photons and Protons 75
Semiautomatic method to identify the best phase for gated RT in lung region by 4D-PET/CT acquisitions 74
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low–Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients 74
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 74
RapidPlan head and neck model: the objectives and possible clinical benefit. 73
FIVE FRACTIONS LINAC BASED SBRT FOR LOW - INTERMEDIATE RISK PROSTATE CANCER: PRELIMINARY REPORT OF A PHASE II STUDY WITH FLATTENING FILTER FREE DELIVERY AND SPACE OAR 73
Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy 73
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments 72
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 72
Is Stereotactic Body Radiation Therapy an Attractive Option for Unresectable Liver Metastases? A Preliminary Report From a Phase 2 Trial 72
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. 72
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience 71
MLC parameters evaluation in a RT-dedicated MC environment (PRIMO) from static fields to VMAT plans 71
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma 70
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors 70
Moderate hypofractionation and SIB with volumetric modulated arc therapy (RapidArc) for anal cancer 70
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 70
Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment 69
CLINICAL OUTCOME OF HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY FOR ABDOMINAL LYMPH NODE METASTASES 69
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments 69
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up 69
MULTIMODAL APPROACH TO THE MANAGEMENT OF METASTATIC EPIDURAL SPINAL CORD COMPRESSION (MESCC) DUE TO SOLID TUMORS 68
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer. 68
Evaluation of a radiotherapy-dedicated Monte Carlo environment in clinical VMAT plans. 68
Hypofractionated Stereotactic Radiotherapy and Radiosurgery for the Treatment of Patients with Radioresistant Brain Metastases 68
Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma Feasibility and tolerability in elderly and chemotherapy-ineligible patients 68
Development of an immobilization device for Total Marrow Irradiation 67
Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy. 67
SABR in inoperable liver oligometastatic patients and radioresistant primary tumors 67
MLC parameters from static fields to VMAT plans: an evaluation in a RT-dedicated MC environment (PRIMO) 66
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: Preliminary report of a phase II study 66
Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy. 66
Total Marrow Irradiation: A Clinical Evaluation of a Volumetric Modulated Arc Therapy Technique 66
Impact of C-11-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors 66
Does deep inspiration breath hold reduce plan complexity? Multicentric experience of left breast cancer radiotherapy with volumetric modulated arc therapy 66
What is the role of [11C]choline PET/CT in decision making strategy before post-operative salvage radiation therapy in prostate cancer patients? 66
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy 65
Study of the radioluminesence spectra of doped silica optical fibre dosimeters for stem effect removal 65
PRECLINICAL ASSESSMENT OF VOLUMETRIC MODULATED ARC THERAPY FOR TOTAL MARROW IRRADIATION 65
Re-irradiation of metastatic spinal cord compression: A feasibility study by volumetric-modulated arc radiotherapy for in-field recurrence creating a dosimetric hole on the central canal 65
Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study 65
Are pitch and roll compensations required in all pathologies? A data analysis of 2945 fractions. 64
Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc 64
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy. 64
Performance of a Knowledge-Based Model for Optimization of Volumetric Modulated Arc Therapy Plans for Single and Bilateral Breast Irradiation. 64
Unresectable Locally Advanced Non-small Cell Lung Cancer: Early Clinical Experience for Large Volume Targets using Volumetric Modulated Arc Therapy 64
Total monitor units influence on plan quality parameters in volumetric modulated arc therapy for breast case 64
Cone beam CT pre- and post-daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer 64
Influence of "radioresistant" histologies on SBRT outcome for lung metastases 64
Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy. 63
Hypofractionation with VMAT versus 3DCRT in Post-operative Patients with Prostate Cancer. 63
Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy 63
Phase I-II Study of Hypofractionated Simultaneous Integrated Boost (SIB) for Adjuvant Radiation Therapy in Early Breast Cancer Patients: A Report of Feasibility and Acute Toxicity Results in the First 50 Treatments 63
Lean-six-sigma methodology for improving quality in RT: the breast daily repositioning case 63
Phase III randomized trial comparing two modalities of RS for brain metastases: Gammaknife vs Linac 63
Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: Report of dosimetric and early clinical results in oligometastatic patients 63
Role of SBRT with VMAT technique and FFF beams for lymph-node metastases in oligometastatic patients from genitourinary malignancies 63
GAMMAKNIFE VERSUS LINAC BASED (EDGE) RADIOSURGERY (SRS) FOR PATIENTS WITH LIMITED BRAIN METASTASES (BMS) FROM DIFFERENT SOLID TUMOR: A PHASE III RANDOMIZED TRIAL 63
Automatic planning of the lower extremities for total marrow irradiation using volumetric modulated arc therapy 62
Reply to the Letter to the editor on Cranio-spinal irradiation with volumetric modulated arc therapy by G. Saini et al. 62
SBRT In Oligometastatic Ovarian Cancer: A Promising Therapeutic Approach 62
Randomized Phase III Trial Comparing Gamma Knife and Linac Based (EDGE) Approaches for Brain Metastases Radiosurgery: Results from the Gadget Trial 62
RapidArc AND IMRT FOR MALIGNANT PLEURAL MESOTHELIOMA COMPARISON AND FEASIBILITY STUDY 62
Predictive model of the dose to the heart based on geometry evaluation in left breast radiotherapy 62
Multicentric Pre-Treatment Quality Assurance Study on first 166 Patients Treated with Truebeam using Flattering Filter Free Beams 62
Low dose total marrow/total lymphoid irradiation (TMI/TLI) instead of TBI induce full donor chimerism before T-replete haploidentical transplantation (TR-H). 62
STEREOTACTIC BODY RADIOTHERAPY (SBRT) USING VOLUMETRIC MODULATED ARC THERAPY (VMAT) WITH FLATTENING FILTER FREE (FFF) MODALITY FOR MEDICALLY INOPERABLE EARLY STAGE NON SMALL-CELL LUNG CANCER (NSCLC): A PROSPECTIVE SINGLE INSTITUTIONAL EXPERIENCE 62
Totale 8.553
Categoria #
all - tutte 78.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021355 0 0 0 0 0 0 0 0 0 186 1 168
2021/2022715 42 8 10 200 4 3 30 122 69 56 151 20
2022/20232.230 338 44 179 261 191 192 3 194 435 188 180 25
2023/20241.081 73 137 252 45 41 92 29 39 54 25 118 176
2024/20251.611 26 40 31 20 34 189 107 205 224 394 186 155
2025/20265.457 658 454 987 533 142 185 1.252 529 470 247 0 0
Totale 12.798